Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, GeneArt Add Insect, Mammalian Synthetic Genes to Marketing Collaboration

NEW YORK (GenomeWeb News) – GeneArt said today it has extended its strategic collaboration with Qiagen to include the sale of synthetic genes optimized for mammalian and insect cells online through Qiagen’s GeneGlobe web portal.
GeneArt said it will optimize and synthesize the QIAgenes, which will be aimed at customers in the pharmaceutical and biotechnology industries and academia.
The companies agreed in May of this year to collaborate on marketing a set of plasmids containing synthetic genes that represent the entire human genome.
“Since the launch of our expression kits for use in E. coli cells in May, we have received a high number of requests for these two additional options,” Qiagen Global Product Manager Ute Boronowsky said in a statement.
GeneArt also said that marketing the QIAgenes products as a standardized catalog product complements the company’s existing business to tailor gene sequences for individual customer requests.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.